Online inquiry

IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK19592MR)

This product GTTS-WK19592MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the Aldehyde Dehydrogenase 1-A1 protein. This product can be used in Cancer stem cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_000689.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 216
UniProt ID P00352
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Aldehyde Dehydrogenase 1-A1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK19592MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK10905MR IVTScrip™ mRNA-Human ACAD11, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ACAD11
GTTS-WK18314MR IVTScrip™ mRNA-Human AGPS, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA AGPS
GTTS-WK9961MR IVTScrip™ mRNA-Human ABHD12B, (Cap 0, 2-Thio-UTP, 30 nt-poly(A)) mRNA ABHD12B
GTTS-WK20211MR IVTScrip™ mRNA-Human ALG1, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ALG1
GTTS-WK21177MR IVTScrip™ mRNA-Human ANGEL1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ANGEL1
GTTS-WK3331MR IVTScrip™ mRNA-Human ZAP70, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ZAP70
GTTS-WK26422MR IVTScrip™ mRNA-Human APOBEC3F, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA APOBEC3F
GTTS-WK14051MR IVTScrip™ mRNA-Human ADHFE1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADHFE1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW